Company Filing History:
Years Active: 1999-2000
Title: The Innovations of Inventor Luis Da Costa
Introduction
Luis Da Costa, located in Columbia, MD, is a recognized inventor with a focus on advancements in genetic expression and tumor biology. With a total of two patents granted, he has made significant contributions to the understanding of gene control mechanisms in relation to cancer treatment.
Latest Patents
One of Luis Da Costa's notable patents is for the selective expression of desired genes in cells expressing oncoproteins. This invention addresses the challenges of tumorigenesis caused by gene alterations that impact cell growth and death. By leveraging the proteins encoded by these genes, his approach targets specific tumor cells for gene expression. Essentially, the endogenous cellular oncoprotein interacts with exogenously introduced gene products, enabling the transcriptional activation of a desired gene. This innovative method possesses broad applications, potentially extending to other diseases where specific proteins are selectively expressed in affected cells compared to healthy ones.
Career Highlights
Luis Da Costa is affiliated with The Johns Hopkins University, where he has dedicated his research to unraveling complex genetic mechanisms. His work contributes to the evolution of targeted therapies aimed at cancer treatment, showcasing his commitment to advancing medical science through innovation.
Collaborations
Throughout his career, Luis has had the privilege of collaborating with prominent scientists such as Bert Vogelstein and Kenneth W Kinzler. These professional partnerships have been pivotal in driving research forward and enhancing the impact of his inventions on the scientific community.
Conclusion
Luis Da Costa's innovative work in selective gene expression exemplifies the critical intersections between genetics and cancer research. With his patents and collaborations, he continues to pave the way for future breakthroughs in medical therapies, positioning himself as a valuable contributor to the field of biomedical innovation.